INTRODUCTION
Diarrhoeal diseases and enteric infections are major causes of morbidity and mortality in the developing countries. In the United States, Shigellosis is an important cause of gastroenteritis, resulting in an estimated case of 450,000 each year. 1 Prompt treatment with effective antimicrobial agents may shorten the duration of clinical symptoms and carriage, and reduce the spread of infection. 2, 3 Tetracycline, Chloramphenicol, Ampicillin, and Trimethoprim-sulfamethoxazole have all in succession been used as first-line antimicrobial drugs in China along with oral rehydration solution and antiprotozoal drugs. However, over the past few decades Shigella spp. have become progressively resistant to most of the first-line drugs used. 4, 5 At present, multi-drug resistance has complicated the selection of empirical agents for the treatment of Shigellosis, particularly in children. 6 The chromosomal multiple antibiotic resistance (mar) locus of Escherichia coli and other members of the Enterobacteriaceae controls resistance to multiple, structurally unrelated compounds including antibiotics, household disinfectants, organic solvents and other toxic chemicals. 7 Present study assess the patterns of antimicrobial susceptibility and mutations in marA and marR genes of Shigella isolates and its association.
MATERIALS AND METHODS

Bacterial isolation and antimicrobial sensitivity:
The Shigella spp. were isolated from stool of acute gastroenteritis patients attending out-patient department at Sunsari district hospitals and private clinics at Inaruwa Municipality of Nepal from May 2008 to October 2009, after fallowing standard bacteriological processing. Antimicrobial sensitivity study was performed by disc diffusion method (Kirby-Bauer) according to the Clinical Laboratory Standard Institute (CLSI) for the following antimicrobials: ciprofloxacin,norfloxacin, ampicillin, tetracycline, chloramphenicol, trimethoprim, gentamicin and streptomycin. Escherichia coli ATCC 25922 was used as quality control strain for all sensitivity tests.
DNA extraction and PCR amplification:
Fiftythree strain of Shigella spp. (28 S. flexneri and 25 S. dysenteriae) were isolated in 2009 from stool of acute gastroenteritis patients attending out-patient department at district hospitals in Eastern Nepal after following standard bacteriological processing. For genomic DNA extraction, strains were grown overnight in LB medium at 37 o C and a loopful of the colony was suspended in 1000μL of ddH2O in microcentrifuge tube. The sample was boiled for 10 min at 100°C and then centrifuged at 12,000 rpm for 5min. The supernatant was stored as a source of DNA at −20°C and sent to molecular epidemiology laboratory of Zhengzhou University, China for further molecular analysis. The extracted DNA was amplified in a 25 μL reaction mixture containing 17 μL ddH2 O, 2.5μL 10X Taq buffer, 2 μL dNTP mixture (2.5 mM each), 0.5μL Taq Polymerase, 0.5μL Primer 1, 0.5μL Primer 2 (Tiangen Biotech Beijing co. Ltd) with 2μL DNA template. All primers from the conserved regions of marAR of Escherichia coli were selected. marA primers were A1: 5'-CTG CGT AAA CAA AA -3' and A2: 5'-GTC ACG TTA TCA ACT ACG-3'; amplification fragments contain 425 bp. marR primers were R1: 5'-AAA CAA GGA TAA AGT GTC A-3' and R2: 5'-AAT GGT AAT AGC GTC AGT A-3'; amplification fragments contain 647 bp. The reaction mixture was subjected to initial denaturation at 95° C for 5min followed by 35 cycles at 94° C for 1min, 42.3 °C (marA)/ 51° C (marR) for 1 min, 72° C for 1 min and a final cycle at 72° C for 10 min.
Restriction enzyme digestion:
In a 25 μl reaction mixture, 15 μl of PCR product was digested with 2.5 units of each restriction enzyme in separate 0.2 ml tubes for 16 hrs at 68°C. The restriction enzyme was TaqI. Ten µl of the restriction enzyme digested PCR product was separated by electrophoresis through a 2 % agarose gel containing ethidium bromide in 1 × Tris-acetate-EDTA (TAE) buffer at 80 V for 30 min and was then visualized under UV light. The enzyme digested product of marA into 82, 139 and 204 bp and marR into 289 and 358 bp.
Single-strand conformation polymorphism (SSCP) analysis: The SSCP of the PCR products were analysed by electrophoresis with 30% acrylamide gel. In brief, 10μL of the amplified PCR product was mixed with 10μL of loading buffer (95% formamide, 20mM EDTA, 0.05% each of bromophenol blue and xylene cyanol). The mixture was denatured by heating at 98° C for 5min, cooled on ice and then loaded on to the non-denaturing gel at 200V for 4 hours at 4 0 C. The gel was then silver stained and a photograph was taken. A DNA marker was run alongside the clinical isolates. A change in the banding patterns as compared with the DNA marker was taken as an indicator for mutation.
Statistics: Statistical analyses were conducted using SPSS 11.5. Categorical variables were compared by the Pearson and continuity correction Chi-square, and P<0.05 was considered statistically significant. norfloxacin showed mutation, 57.1%resistant and 54.5% non resistant phenotype of tetracycline and streptomycin showed mutation. The rate of mutation among phenotype resistant with gentamicin was 90% whereas non resistant phenotype showed 48.8%. Table 4 describes the association among antimicrobial resistant phenotype and mutation in marR gene. Study revealed that none of the resistant strains of ciprofloxacin and norfloxacin showed mutation in marR gene whereas 57.8% non resistant strains had mutation. Similarly, the mutation was observed in 47.6% resistant and 54.5% non resistant phenotype with tetracycline and streptomycin. Similarly, mutation was observed in none of the resistant phenotype and 70.3% non resistant phenotype of chloramphenicol. And, also mutation was observed in 42.6% resistant and 100% non resistant phenotype of trimethoprim.
RESULTS
Study also revealed that the rate of mutation with marA gene was 67.9% in S. flexneri and 44% in S. dysenteriae strains, similarly, with marR gene was 46.4% in S. flexneri and 52% in S. dysenteriae strains (Table 1) .
It is noted that there is no significant association with number of antimicrobial resistance by a Shigella isolates with mutation in marAR gene ( Table 2) . 
DISCUSSION
In present study, we found S. flexneri was predominant strains and similar study also noted the same result 8 whereas, some author reported S. dysenteriae were common in Nepal 9 and other developing countries like China 10 . However, S. sonnei was predominant in developed countries. 11, 12 In present study, there is high rate of mutation in gene marA and marR as 56.6% and 46.6% respectively among the Shigella isolates. Study from other Gram negative bacteria revealed that antibiotics such as B-lactams 13 chloramphenicol and fluoroquinolones permeate the Gram-negative outer membrane via porins. As such, changes in porin copy number, size or selectivity will alter the rate of diffusion of these antibiotics. 14 One of the first examples of antibiotic resistance due to porin loss was a clinical isolate of S. marcescens that exhibited resistance to both aminoglycosides and B-lactams. Additional examples have since been reported with various bacterial isolates, including E. Mechanism of multidrug resistance in Shigella spp.
coli 15 , Enterobacter cloacae 16 and S. enterica. 17 In E. aerogenes, B-lactam resistant isolates often exhibit loss of a porin along with the expression of Blactamase, 18 but resistance can also result from mutations that lead to a narrowing of the porin channel. 19 In E. cloacae, meropenem resistance resulted from loss of porins. 20 B-Lactam resistance of K. pneumoniae often results from loss of porins as well, though usually in conjunction with Blactamase production. 21 A mutation in a porin gene in N. gonorrhoeae was shown to be responsible for resistance of this organism to B-lactams and tetracycline. 22 
CONCLUSIONS
Study revealed that there is significant association in between ciprofloxacin, norfloxacin and gentamicn with mutation in marA gene. However, there is no significant association in between tetracycline, streptocycin and ampicillin. Similarly, it is observed that negative association in between antimicrobial resistance with mutation in marR like ciprofloxacin, norfloxacin, chloramphenicol, gentamicin and trimethoprim.
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